IUVANTIUM LIMITED

OX44 7RW (South East)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£49,143

May 23 - Nov 23

Inorganic functional immunomodulators targeting Th-17 immune response for vaccines and cell therapies

Innovate UK award to IUVANTIUM LIMITED and Björn Schimmöller

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}